3-D printing could be transformative in healthcare by empowering clinicians to quickly create high-quality and affordable custom medical implants, but we need more resins that are biocompatible and can be safely destroyed and absorbed into the body after use. Gene therapies aim to attack disease at the source by inhibiting or correcting the production of problematic proteins BEFORE they have a chance to replicate and require traditional drugs. However, like the resins in additive manufacturing, there are challenges to the body tolerating this new technology, for example rapid renal clearance, inefficient delivery to non-liver organs, and immunogenicity/toxicity.
Polymer scientists are working to develop new technologies to augment and support game-changing treatments like gene therapy and 3-D printed implants so that our bodies can safely tolerate their effects leading to wider use and better outcomes. In this extended webinar from the ACS Division of Polymer Chemistry, Matthew L. Becker of Duke University will outline strategies for synthesizing highly functional oligomeric resins that can be photochemically printed into a variety of structures possessing unique mechanical, chemical and degradation properties, including a number of pre-clinical applications. Then, Ke Zhang of Northeastern University will share how his lab is developing a safe and efficient oligonucleotide delivery technology that addresses non-liver organs, reduces cost, and minimizes off-target effects for gene therapy.
This ACS Webinar is moderated by Adrian Figg of Virginia Tech and is co-produced with the ACS Division of Polymer Chemistry.
What You Will Learn
- Synthetic methods of novel resorbable resins for photochemical 3D printing
- How 3D printed medical devices can be characterized and evaluated
- Near term opportunities for translation of custom resorbable devices to the clinic
- Important considerations for oligonucleotide delivery
- How does bottlebrush polymers work to enhance oligonucleotides delivery
- Promising results for several disease indications
What an attendee said about this ACS Webinar!
Fantastic talks on cutting edge technologies